NEW YORK, June 27, 2024 (Newswire.com) - Black Book Research has declared Waystar the top vendor for Revenue Cycle Management Software Technology, recognized as the best by clients from large hospitals, academic medical centers, health systems, chains, and IDNs. This accolade comes from the 2024 RCM survey responses of hospital executives, financial system users, and business office leaders representing 680 inpatient organizations.

Between Q4 2023 and Q2 2024, the Black Book Research financial digital transformation software survey rigorously evaluated 307 vendors across various finance functional categories. This assessment drew on feedback from 6,195 verified client users to determine the top-rated solutions vendors.

In a competitive landscape filled with hundreds of core and niche Revenue Cycle Management (RCM) solution vendors, the latest Black Book survey respondents assessed various healthcare provider technology tools. Waystar has consistently earned top customer satisfaction ratings in Black Book's annual surveys for over a decade, maintaining its premier status since 2012.

"Waystar excels in revenue cycle management by leveraging AI and ML for predictive analytics to forecast patient payment behavior, identify denials, and optimize claims," said Doug Brown, President of Black Book Research. "Their enhanced data analytics tools ensure revenue integrity with accurate billing and compliance, while patient engagement features like online payment portals, real-time claim updates, and personalized payment plans improve communication and transparency. By emphasizing interoperability, Waystar seamlessly integrates with EHRs to streamline workflows. Additionally, they support value-based care with tools for managing bundled payments and tracking quality metrics, and their advanced security features ensure data protection and HIPAA compliance. These comprehensive capabilities have secured Waystar's top client rating for the ninth consecutive year in end-to-end RCM services."

Waystar achieved the highest scores in 12 out of 18 key performance indicators for revenue cycle management, including Strategic Alignment of Client Goals, Innovation, Training, Trust, Transparency, Accountability, Breadth of Offerings, Deployment and Implementation, Customization, Brand Image and Marketing Communications, Marginal Value Adds, Viability and Managerial Stability, Support and Customer Care, and Best-of-Breed Technology and Process Improvement.

Full results can be found at https://blackbookmarketresearch.com/finance-revenue-cycle-management.

About Black Book

Black Book conducts crowdsourced polls and surveys with healthcare executives and front-line users about their current technology trends, and services partners and awards top-performing vendors' recognition based on performance using indicators of client experience, loyalty, and customer satisfaction. Black Book™, along with its founder, management, and staff, holds no financial interest in any of the vendors, including Waystar, covered in its RCM surveys. Black Book publishes the results of satisfaction and client experience rankings and shares them with the media before notifying the vendors. It does not solicit participation fees, review fees, inclusion or briefing charges, or vendor collaboration during its client polls. For methodology, auditing, resources, comprehensive research, and ranking data, see www.blackbookmarketresearch.com or contact us at [email protected].

Panoramic Health Logo

TEMPE, Ariz., June 27, 2024 (Newswire.com) - Today, Panoramic Health, the largest integrated nephrology provider group, is proud to announce that it has achieved HITRUST CSF® certification, underscoring the company's commitment to maintaining the highest standards of information security and privacy. This certification validates Panoramic Health's adherence to the rigorous requirements of the HITRUST Common Security Framework (CSF), a globally recognized standard for managing information security.

HITRUST certification represents the gold standard for information security, demonstrating compliance with the HITRUST CSF's comprehensive set of security and privacy requirements. This certification encompasses more than 40 standards and regulations, including HIPAA, HITECH, PCI, GDPR, NIST, ISO, and various state-specific regulations, ensuring a robust and comprehensive approach to data protection.

"We are incredibly proud to have achieved HITRUST certification after undergoing a thorough third-party assessment of our controls, policies, and procedures over the past year," said Sampath Narayanan, Chief Information Officer of Panoramic Health. "This milestone is a testament to our unwavering commitment to protecting sensitive data and maintaining the trust of our partner practices, their patients, our employees, and customers. It reflects the hard work and dedication of our teams who have meticulously worked to meet the highest security standards."

Achieving HITRUST certification highlights Panoramic Health's dedication to comprehensive risk management, robust security controls, regulatory compliance, and third-party vendor risk management. It demonstrates Panoramic Health's proactive approach to managing information security risks and reinforces its reputation as a secure and reliable platform for prospective clients, including payers, pharmaceutical organizations, clinical research organizations, and medical practices.

As Panoramic Health continues to prioritize security and compliance, it remains steadfast in its mission to provide a safe and secure environment for all stakeholders. The HITRUST certification reinforces Panoramic Health's commitment to protecting data and maintaining the highest standards of trust and security. For more information, visit our website. 

About Panoramic Health

Panoramic Health is kidney care’s leading integrated provider group, with 600 aligned providers across 13 states serving more than 300,000 patients. We are committed to improving outcomes for patients by slowing disease progression and improving quality of life, keeping patients healthier, longer at home, and out of the hospital. At the core of our success lies the deep integration with partner nephrologists and the distinctive capabilities of our physician-led, comprehensive clinical care model. Through partnerships with practices, providers, and payers, we work to advance the usage of clinical best practices and cutting-edge data analytics to improve outcomes across a continuum of reimbursement models. Panoramic Health's clinical research division, Panoramic Science, collaborates with sponsors and clinical research organizations to pioneer cutting-edge treatments for patients with kidney disease. 

For more information, please contact [email protected].

VMeDx virtual medical assistant
Virtual medical assistants working in the office

NASHVILLE, Tenn., June 27, 2024 (Newswire.com) - VMeDx, a leading virtual assistant provider, is set on transforming the world of healthcare by offering highly skilled and HIPAA-compliant virtual medical assistants to healthcare practices worldwide. These virtual assistants serve as the helping hands healthcare professionals need to focus on delivering patient care. Having a virtual assistant also results in improving their work-life balance and overall practice efficiency.

Virtual Medical Assistant Provider Offers Solutions to Enhance Patient Care and Streamline Practice Operations

"VMeDx has a heart. They have a heartbeat. They really care and have compassion," said Dr. Ronald Espinosa, a Cosmetics, Plastic Surgeon, and client of VMeDx. "VMeDx has given me this great opportunity to run my practice more efficiently. In my company, employee turnovers are one of my greatest hurdles but VMeDx makes sure that my staff is happy and chooses to stay with me for a very long time."

End-to-End Virtual Medical Assistant Services

To help healthcare providers like Dr. Espinosa, VMeDx's virtual medical assistants offer a range of services, including:

• Live answering calls and managing appointments
• Remote patient monitoring and support
• Medical billing and insurance verification
• Specialized assistance for veterinary and dental practices
• Prior authorization and medical scribing

Benefits for Healthcare Providers

With the expertise of VMeDx's Virtual Medical Assistants, healthcare providers can expect:

• Increased patient satisfaction and loyalty
• Improved communication within the practice
• Enhanced productivity and accuracy, reducing errors
• Significant cost savings compared to hiring in-house staff

About VMeDx

VMeDx is a leading virtual assistant provider in the healthcare industry. With a team with years of experience and highly skilled virtual medical assistants, VMeDx has successfully supported healthcare practices across the United States and the globe. VMeDx ensures its virtual assistants are equipped to handle the evolving healthcare industry needs while maintaining HIPAA standards through continuous education and training.

Discover more about VMeDx and its virtual medical assistant services:

Contact Information:

Vladimir Gasic
CEO & Co-founder
VMeDx 
[email protected]
+1 615-866-1649
101 Bear Track Drive, Nashville, TN, 37221 USA

Dogs & Lagers Fest | Aug. 24, 2024 | Crux Fermentation Project

BEND, Ore., June 27, 2024 (Newswire.com) - The Veterinary Referral Center of Central Oregon is excited to announce that the VRCCO Care Fund will be this year’s beneficiary of the Dogs & Lagers Fest on Aug. 24, 2024, at Crux Fermentation Project. This event is brought to you by Crux and Bend Pet Express and will take place from 11 a.m. to 6 p.m. on the Crux Bend Lawn at 50 SW Division Street in Bend, Oregon. 

The Dogs & Lagers Fest will be a fun-filled day to celebrate Bend's community of pet-parents and their beloved dogs. This event will include live music, local vendors and, of course, delicious beer and food from Crux Fermentation Project. The first 25 dogs to arrive at Dogs & Lagers will receive a swag bag from Bend Pet Express. Plus, commemorative tasting mugs will be available for $20 and will include two beer tokens; additional tokens will be available for purchase for $6.50 per token. 

The Veterinary Referral Center will also be hosting an “Ask a Vet” booth. VRCCO veterinarians look forward to connecting with pet-parents outside of the hospital environment to lend some helpful advice throughout the afternoon. 

Even more exciting is the special-edition lager that will be served at this event. VRCCO and Ponch’s Place have collaborated with Crux to develop a Mexican Lager that will benefit the VRCCO Care Fund to help Central Oregon’s pets. VRCCO was honored to take part in this unique team-building experience. Creating a special-edition lager for an animal-inspired community event that benefits VRCCO Care Fund is a full-circle initiative that VRCCO and Ponch’s Place are proud to be a part of.

The VRCCO Care Fund uses 100% of its funds to provide financial assistance to pet-parents in the community facing financial hardship. The funds raised will provide medical services to the neglected, abused and financially constrained animals with otherwise good prognoses that find their way into the VRCCO Emergency and Specialty Hospital. 

The VRCCO and Ponch's Place team hopes that you are able to come and enjoy this collaborative beer at the Dogs & Lagers Fest on Aug. 24. For more information, please visit https://www.cruxfermentation.com/dogsandlagers/. If you are unable to attend this event and would like to donate or learn more about the VRCCO Care Fund, please visit our website: https://vrcvet.com/donations/.

The Veterinary Referral Center of Central Oregon offers the most advanced emergency and specialty care options to members of the Central Oregon community and beyond. Ponch’s Place, a food truck and beer pavilion at VRCCO, is a space for the Bend community to gather for local food, drinks and entertainment.  www.vrcvet.com  |  www.ponchsplace.com

Founded in 2012, Crux Fermentation Project is a brewer-owned and operated community of craft beer lovers based in Bend, Oregon.  www.cruxfermentation.com

QUAKERTOWN, Pa., June 27, 2024 (Newswire.com) - Artificial intelligence is everywhere this year and is having an especially large impact on dentistry. With the first four months of 2024 complete, DEXIS, a technology leader in dental imaging, has identified four leading trends in AI and dentistry that are already having an impact on dental care.  

Wouter Mollemans, Head of Software Development at DEXIS, notes, “At DEXIS, we believe technology is always in service to dental practitioners, supplementing their skills, experience, and relationship with their patients."   

"Overall, I see a growing integration of AI technologies across various aspects of dental practices, from diagnosis and treatment planning to education and research,” Mollemans said. “I expect to see more specialized advancements specific to each branch or specialty within dentistry – implants, endodontics, orthodontics, restorative dentistry, and more.”  

Mollemans has four predictions for dentistry AI trends in 2024:   

AI Imaging Analysis: AI algorithms analyze dental radiographs, CT scans, digital impressions, and intraoral photos. Mollemans says the results assist dentists in more efficient diagnosis, treatment planning, and oral health monitoring.   

These functions are built into the DEXIS ecosystem’s imaging hub, DTX Studio™ Clinic, making it the first on-premise dental imaging system with assisted intelligence tools that can concurrently identify common dental findings on 2D radiographs. These dental findings include: caries, calculus, periapical radiolucency, root canal filling deficiency, discrepancy at margin of an existing restoration and bone loss. Moreover, DTX Studio Clinic automatically analyzes any loaded CBCT scan to set up diagnostic workspaces and trace the mandibular nerve canals.  

Predictive Analytics: AI was developed to analyze so-called “big data” to spot patterns and make recommendations.   

In dentistry, Mollemans notes, AI-powered software can analyze patients’ case histories to improve dental practices’ workflow efficiency – identifying the number of missed caries, performing automated image IQ checks, and more.  In the future, refinements to dental AI may be able to forecast a patient’s potential to develop conditions such as gum disease and possibly help dentists begin care and treatment earlier.  

Integrated AI Workflows: Mollemans sees early-adopter dental practices already incorporating functions into hardware, like digital imaging equipment, that will allow their software to execute crucial AI-driven tasks. This should allow dentists to spend less time on straightforward steps and more time on things that really matter – for example, spending less time to load a CBCT scan affords more time for diagnosis and treatment planning. “This will be one of the key elements to discover and explore as a dentist in 2024,” Mollemans said.  

DTX Studio Clinic incorporates AI tools that simplify dental practitioners’ work. For example, SmartFusion™ fuses cone-beam CT scans (CBCT) with intraoral scan data, creating a 3D view of the underlying anatomy and providing deeper visibility to diagnose and treat.  

Ongoing AI investment: DEXIS has already made significant investments into developing dental-specific AI technologies, and Mollemans sees patients as the big winners in this scenario. 

“Assisted intelligence in dental imaging can improve patient outcomes, streamline diagnosis through treatment, and enhance the overall delivery and predictability of dental care,” Mollemans said. “But it can’t just be technology for technology’s sake. At DEXIS, we always think about how technology can help patients and practitioners.”  

About DEXIS  
DEXIS has been a global leading brand in digital radiography for 70+ years. Today, DEXIS has brought together the most trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software to provide patients with a complete digital diagnostic solution under a brand name. Our innovative award-winning technology enhances how the patient is diagnosed, accelerates the workflow, and delivers simple treatment paths with better patient outcomes. For more information, please visit https://www.dexis.com.  

ATLANTA, June 27, 2024 (Newswire.com) - Ascend Aesthetic Partners, a network of 12 plastic surgery and aesthetic centers across the nation, proudly announces its pivotal rebrand from Ascend Plastic Surgery Partners, marking a significant milestone in advancing aesthetic medicine. This transformation underscores Ascend’s dedication to enhancing patient care and fostering a collaborative community among top-tier plastic surgeons nationwide.

"The landscape of aesthetic medicine is constantly evolving, and Ascend Aesthetic Partners is at the forefront of that change," stated Dr. William Hedden, Chief Medical Officer. "This rebrand reflects our ongoing commitment to patient-centered care and continuous professional growth."

Grounded in the principles of clinical leadership and collaboration, shared learnings, education and community building, Ascend Aesthetic Partners brings together a network of renowned surgeons who are dedicated to elevating standards in the field. This commitment to continuous improvement is furthered by the esteemed Clinical Advisory Board, comprised of industry leaders like Dr. Kimball Crofts of Aesthetica Plastic Surgery (Lindon, UT) and Dr. Thomas McFadden Jr. of Advanced Cosmetic Surgery (Greenville, SC).
 

Introducing a New Purpose, Vision and Values:

As part of its rebranding initiative, Ascend Aesthetic Partners has unveiled a new purpose and vision that guides its mission to renew, restore and foster self-confidence and overall well-being in patients. Developed through iterative sessions with core working groups, these values are foundational to Ascend's culture and underscore its commitment to excellence in aesthetics and compassionate patient care.

"Our rebrand goes beyond a new name and logo; it signifies our renewed purpose to guide patients towards their optimal selves and our vision to establish premier centers of excellence in aesthetics," said Anthony Milonas, CEO of Ascend Aesthetic Partners. "Our values of excellence, compassion, community, accountability and creating a winning team are integral to our culture. They reflect our commitment to patient-centered care, collaborative community building and maintaining the highest standards in aesthetic medicine."

The launch of Ascend Aesthetic Partners coincides with the unveiling of its new website, www.AscendAestheticPartners.com, designed to showcase the network's capabilities and facilitate access to its comprehensive suite of services. 

Ascend's dedication to patient care is exemplified by their patient-first focus.

"Imagine a practice where you can focus solely on your patients, knowing the operational and administrative responsibilities are expertly handled, that’s what Ascend aims to deliver to our partners," explained Dr. Crofts.

As part of its commitment to growth, Ascend Aesthetic Partners offers strategic investment opportunities and advanced support services in finance, HR, marketing and operational management for the plastic surgery and aesthetic practices they serve. These initiatives are tailored to help practices thrive in a competitive healthcare landscape while maintaining a patient-first approach.

"We are excited to embark on this new chapter as Ascend Aesthetic Partners," added Dr. McFadden. "Our focus remains steadfast on supporting our partners in achieving their professional goals and delivering exceptional care to our patients."

Interested surgeons can learn more about how Ascend's network, expertise and support services can empower their practice and elevate patient care. If interested in joining this premier network, visit their new website at www.AscendAestheticPartners.com to explore Ascend’s comprehensive suite of services.

About Ascend Aesthetic Partners: Ascend Aesthetic Partners is a leading management services organization dedicated to redefining excellence in plastic surgery and aesthetic care. With a focus on clinical leadership and collaborative growth, Ascend provides comprehensive support to its network of top-tier surgeons across the country. For more information about Ascend Aesthetic Partners and its services, visit www.AscendAestheticPartners.com.

Neuro20 Technologies
Neuro20 Technologies Logo

TAMPA, Fla., June 27, 2024 (Newswire.com) - Neuro20 Technologies Corp., announces release of a White Paper discussing patient improvements and potential mechanisms for patients with Long COVID, specifically with fatigue, movement, and neurological symptoms. Neuro20 is a medical technology manufacturer with an FDA cleared wearable device that involuntarily moves up to 44 muscles in a series of pre-designed sequenced movement patterns.

Since April 2024, doctors utilized the device for seven patients diagnosed with Long Covid. It demonstrated levels of improvement for symptoms and quality of life for all seven patients. Two patients used walkers coming into the clinic and left without a walker following one treatment.

The device is a physical modality, worn by the patient, that is FDA medically cleared (Feb. 2023) and Medicare Durable Medical Equipment approved (Feb. 2024). The FDA Indications of Use are facilitation of muscle performance, re-educating muscles, increasing local blood circulation, maintaining or increasing range of motion, relaxing muscle spasms, and retardation or preventing disuse atrophy, all of which address the underlying symptoms of Long COVID.

The device is intended for injured and diseased tissue, must be prescribed, and has a Use Environment both in clinics and home.

A white paper discussing the theory behind the effects of the device demonstrated in the field may be found at this link. Videos demonstrating the effects of Neuro20 impacting Neuromuscular conditions may be viewed at https://neuro20.com/reviews.

Call to Action - Since COVID-19 emerged scientists struggle to catch up with the aftermath. Long COVID affects approximately 24 million Americans, 65 million people globally. The American Disability Act recognizes Long COVID as a disability, allowing workplace accommodations to keep people in the workforce. Nearly 45% diagnosed with Long COVID are unable to work. A study at Harvard University estimates Long COVID’s cost to the economy will be nearly $3.7 Trillion dollars.

Neuro20 understands that a clinical approach to solving Long COVID must occur through credible randomized controlled trials. Currently, there are 43 federally funded programs and research projects occurring for Long COVID. Neuro20 requests that Long COVID researchers consider conducting trials utilizing the Neuro20 modality and accurately document efficacy. Neuro20's mission is to help all patients gain access to verified quality care, and therefore the device may be utilized in any community, urban or rural, in clinic or at home.

Forward-Looking Statements
This release contains forward-looking statements for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release concerning the Company’s expectations, plans, business outlook or future performance, and any other statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are “forward-looking statements.” Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things: our research, development and regulatory activities and expectations relating to our Neuro20 PRO System; the effectiveness of these programs or the possible range of application and potential curative effects and safety in the treatment of injuries and diseases; the timing, conduct and success of our clinical products, our ability to use our manufacturing facilities to support clinical and commercial demand; and our future operating expenses and capital expenditure requirements. Forward-looking statements are by their nature subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those stated in such statements. The Company assumes no obligation to update our forward-looking statements, whether as a result of new information, future events, or otherwise, after the date of this press release.

About Neuro20 Technologies Corp.

Neuro20 is a registered Delaware C-Corp, founded by a veteran in 2020 to help him recover from his service-sustained injuries. Neuro20 is privately owned, and received initial funding by the Harvard Business School Alumni Angels. After two years in the Tampa Bay Technology Incubator, Neuro20 scaled operations, opened warehousing and offices, and are rapidly growing. Our mission is "Suit Up Together for Better". For more information about the company please visit www.neuro20.com.